A game-changing daily pill for diabetes and weight loss, Foundayo, just launched in UK pharmacies—no needles required. Approved in Europe, it’s the first oral GLP-1 drug of its kind, helping those with high BMI or weight-related health issues—and it’s taken once a day, with no food or water restrictions. While private prescriptions start now, Eli Lilly is pushing for NHS access to expand reach. Pharmacists are thrilled but warning about dangerous counterfeit drugs flooding the market—stick to licensed pharmacies. This breakthrough also sparks calls for fairer, nationwide access to weight management care, ending the postcode lottery. Convenience meets caution: this new option could transform lives—if you get it right.
Listen in comfort: Get a discount on a Soli Pillow: http://solipillow.com/discount/dnn.
Advertise on DNN: advertise@thednn.ai
This is an automated, high-level news summary based on public reporting. Report issues to feedback@thednn.ai.
Podden och tillhörande omslagsbild på den här sidan tillhör
The Daily News Now!. Innehållet i podden är skapat av The Daily News Now! och inte av,
eller tillsammans med, Poddtoppen.
